• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Express Scripts

Express Scripts

Express Scripts ESRX 3 Star

Last Price$80.48Day Change (%)0.68%
Open Price$80.88Day Change ($)0.54
Day Range79.85–80.8852-Week Range64.64–85.72

As of Thu 12/18/2014 06:34 PM EST | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  1. Express Scripts Names New Chief Financial Officer

    Express Scripts Names New Chief Financial Officer

  2. Berkshire Likes Express Scripts --and So Do We

    The wide-moat pharmacy benefit manager--which is currently rated 4 stars by Morningstar--was Berkshire's only new money purchase during the third quarter.

  3. Express Scripts Well Positioned for New Health-Care Order

    The wide-moat pharmacy benefit manager is still undervalued.

  4. Morningstar Minute: 3 Pillars to Express Scripts' Wide Moat

    Pharmacy benefits manager Express Scripts is attractively priced given its ability to fend off competitors for years to come.

  5. Market Overreaction Makes Express Scripts Even More Attractive

    Misunderstanding on private health insurance exchanges could mean opportunity for investors.

  6. A Rare, Wide-Moat Find in a Market With Few Values

    Investors concerned with Express Scripts' integration of Medco are overlooking the firm's long-term potential to benefit from an increased focus on health-care cost-cutting, says Morningstar StockInvestor editor Matt Coffina.

  7. Fixed Income Roadmap: Where Next For Bonds?

    Express Scripts ESRX reported first-quarter results that beat our expectations. The company also increased its earnings-per-share guidance for the year, but more importantly to us, Express Scripts expects higher cash flow from operations in 2007 than it did previously. We're reviewing our model in ...

  8. Health Care: Some Healthy Bargains Still Remain

    While the sector looks fairly valued overall, we still see several stocks that offer attractive valuations across the different industries, including pharmacy benefit managers.

  9. Stock-Picking Increasingly Critical in Health Care

    Despite full valuations overall, we do see some opportunities, especially in pharmacy benefit managers.

Upcoming Events

©2014 Morningstar Advisor. All right reserved.